Navigation Links
Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results
Date:2/28/2008

loss) $2,367 4.7% $(35) -0.1%

Litigation and related expenses - 0.0% 625 1.6%

Tax effect - 0.0% (219) -0.6%

Pro forma net income $2,367 4.7% $371 1.0%

Reconciliation of Net Income to

Pro Forma Net Income

YTD Months YTD Months

Ended Ended

December 31, December 31,

2007 2006

% of % of

revenue revenue

Net income $8,490 4.7% $49 0.0%

Litigation and related expenses 3,808 2.1% 3,855 2.5%

Licensing income and litigation

settlement (6,000) -3.3% - 0.0%

Tax effect 805 0.4% (1,401) -0.9%

Pro forma net income $7,103 3.9% $2,503 1.6%


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
3. Family History Has Strong Effect on Cardiac Risk
4. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
5. Cardiac Science to Present at the UBS Global Life Sciences Conference
6. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
7. Guidelines help patients reduce risk of cardiac event before surgery
8. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
9. Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need
10. Cardiac Science Releases New Cardiac Rehabilitation System
11. Cardiac Artery Trouble Boosts Family Heart Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)... Licensed Chiropractor Dr. Richard A. Huntoon... Newburgh, NY (Vocus) October 7, 2008 -- I...the most stressful times in its history. High gas...s of everything from phone bills to electric to fo... stress. And with growing stress levels come vari...
(Date:10/7/2008)... Mickie Bellah,s Luminescence Series painting...tional Fine Art Gallery in the Chelsea District of... TX (PRWEB) October 7, 2008 -- Austin Artist Micki... her Luminescence Series paintings at Amsterdam Wh...a District of New York City,October 10, 2008. Bell...
(Date:10/6/2008)...not helping fight against childhood obesity, resea...Day News) -- Three-quarters of middle schools have...are sold, a new study finds. , The research dem...middle schools, and "that those vending machines d...dy author Amy Virus, a registered dietitian with t...
(Date:10/6/2008)...6 /PRNewswire-FirstCall/ -- Volcano Corporation,(N...acturing and sales of,products for the diagnosis a...ease, today announced the relocation of its corpor... Cordova to San Diego. The new corporate,headquart...ego and now,houses corporate executives, marketing...
Breaking Medicine News(10 mins):Health News:Prescriptions for Stress 2Health News:Prescriptions for Stress 3Health News:Vending Machines Found in Most Middle Schools 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4
...m, the UNAIDS and UNICEF Special Representative fo...f education, in bettering the lot of the children ...he anti-Aids movement a morale boost. The Princes...ast African Country said 'During the past days, I ...
...new research is to be believed hunger can help wit...revelation comes from American scientists who foun...ry retention. The mechanism is by way of an increa... area of the brain where new memories are formed. ...
...s prompted a bird flu panic across the whole count...ere is no reason for panic even after thousands of... Across the country, state governments began taki... deadly H5N1 strain of the avian flu that is known...
...government is considering the ban on import of egg...tion. // Orissa is currently dependent upon Andhra...gs. A meeting between the Animal Husbandry and Ve...was held recently to alleviate any fears among the...
Other Medicine News:Health News:Indian Government: No Reason For Worry About Bird Flu 2Health News:Indian Government: No Reason For Worry About Bird Flu 3
(Date:10/7/2008)... DIEGO, Oct. 7 /- Ardea Bio...at a poster entitled "RDEA119, a Potent,and Highly...an Sulfate,Sodium (DSS) -- induced Chronic Colitis...f Gastroenterology (ACG) 2008 Annual Meeting in Or...om a preclinical study of,RDEA119, the Company,s l...
(Date:10/6/2008)...NCETON, N.J., Oct. 6 /- Pha...ard E.T. Smith, Ph.D., is joining the,Company as V...Communications. Dr. Smith will be responsible for ...irectly to Chief Financial Officer Kurt,Leutzinger...and Senior Biotechnology,Analyst at JPMorgan Secur...
(Date:10/6/2008)...-winning video clips feature children, parents dis...udies, BETHESDA, Md., Oct. 6 /PRNewswire-USNewswi...es, research in children saves lives and improves ...he National Institutes of,Health (NIH), "Children ...icalStudies.nhlbi.nih.gov ), offers parents and he...
(Date:10/6/2008)...MOUTH MEETING, Pa., Oct. 6 /PRNewswire-FirstCall/ ...rted data from its second Phase 1,clinical trial o...ndidate,for the treatment of type 2 diabetes and o...validated molecular target that controls the funct...malize glucose and decrease,appetite. In the study...
Breaking Medicine Technology:Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Cigarette smoke alcohol damage hearts worse as combo 1307 1Cigarette smoke alcohol damage hearts worse as combo 1307 2The Advisory Board Company to Present at CIBC World Markets Mid 26 Small Cap Best Ideas Conference 6794 1UNT Health Science Center Appoints Eight New Faculty Members 6792 1UNT Health Science Center Appoints Eight New Faculty Members 6792 2UNT Health Science Center Appoints Eight New Faculty Members 6792 3Help Save Lives This Holiday Season by Donating Blood 6790 1Help Save Lives This Holiday Season by Donating Blood 6790 2
... Food and Drug,Administration (FDA) announced the ...against PharmaFab Inc., its subsidiary, PFab,LP, a...s president,and Russ McMahen, PFab,s vice preside...facture and distribution of prescription and,over-...l because,they are not produced according to the r...
...ewswire-FirstCall/ --,Allos Therapeutics, Inc. tod...ommunities, with a favorable opinion of the Commit...Medicines Agency (EMEA),has granted orphan drug d...pralatrexate) for the treatment of patients with,p...e U.S. Food and,Drug Administration (FDA) awarded ...
Other Medicine Technology:Major Manufacturer of Unapproved and Adulterated Drugs 2Major Manufacturer of Unapproved and Adulterated Drugs 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
New Image Drainable Pouch, Ultra-Clear without Filter
New Image Drainable Mini-Pouch, Beige
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange, with Tape
New Image Cut-to-Fit Convex Flextend Skin Barrier, with Tape
Medicine Products: